Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
BMC Ophthalmology|July 18, 2023
Tear fluid and complement activation products in tears after ocular surgeryHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
Japanese Journal of Ophthalmology|May 25, 2020
Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter studyHideki Koizumi, Akiko Yamamoto, Masashi Ogasawara, et al.
American Journal of Ophthalmology|January 4, 2015
Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degenerationHideki Koizumi, Mariko Kano, Akiko Yamamoto, et al.
Japanese Journal of Ophthalmology|July 6, 2018
Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathyMasashi Ogasawara, Hideki Koizumi, Akiko Yamamoto, et al.
Scientific Reports|January 2, 2025
Red blood cell parameters as biomarkers of retinopathy of prematurity in preterm infants born before 30 weeks of gestationHajime Maeda, Hayato Go, Hajime Iwasa, et al.
Scientific Reports|January 3, 2024
Complement activation products in tears of dry eye and meibomian gland dysfunctionHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
Experimental Eye Research|April 1, 2020
Anaphylatoxin concentration in aqueous and vitreous humor in the eyes with vitreoretinal interface abnormalitiesYasuharu Oguchi, Tetsuju Sekiryu, Tomoko Omori, et al.
American Journal of Perinatology|November 7, 2025
Platelet Parameters as Biomarkers for Retinopathy of Prematurity in Preterm Infants Born before 30 Weeks of GestationHajime Maeda, Hajime Iwasa, Miku Munakata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 26, 2026
Long-term analysis of fibrosis in neovascular age-related macular degeneration: A 7-year follow-upJunichiro Honjo, Ryo Mukai, Kanako Itagaki, et al.
Ophthalmology. Retina|May 18, 2020
Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration: A Prospective StudyIchiro Maruko, Masashi Ogasawara, Akiko Yamamoto, et al.
Pageof 12